Adicet Bio, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Adicet Bio, Inc. (ACET) reported Increase (Decrease) in Other Noncurrent Liabilities of -$9.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2022-03-15
- Adicet Bio, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2021-12-31 was -$125.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-12-31 was -$243.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2021 was -$9.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2020 was -$242.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|
| 2021-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$9.00K 10-K · filed 2022-03-15 | |
| 2021-09-30 | $116.00K 10-Q · filed 2021-11-10 | ||
| 2020-12-31 | -$243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$242.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |